Skip to content

PEEP Optimization After Elective Cardiac Surgery: A Pilot Study

PEEP Optimization After Elective Cardiac Surgery: A Pilot Study - PEEP optimization after elective Cardiothoracic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56506
Enrollment
50
Registered
2024-02-23
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardio-thoracale chirurgische aandoeningen Atelectasis collapsed alveoli

Interventions

Participants will be randomly allocated into two groups. One group will have their settings determined through Electrical Impedance Tomography (EIT) measurements, while the other group will have the

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Elective Cardiothoracic surgery Older than 18 year

Exclusion criteria

Exclusion criteria: * Transplantation surgery * COPD GOLD III-IV * Pneumothorax without a chest tube. * Subcutaneous emphysema * Open chest * Chest wall abnormalities * Hemodynamic instability * Contraindications for inserting a nasogastric tube * Pacemaker or implantable cardioverter defibrillator (ICD)

Design outcomes

Primary

MeasureTime frame
The difference in PEEP levels between the baseline setting and the PEEP level established after a decremental PEEP trial using EIT or Pes measurement.

Secondary

MeasureTime frame
* Driving pressure at a tidal volume of 6 ml/kg IBW (Ideal Body Weight). * Dynamic compliance. * End-expiratory lung volume (EELV). * Global Inhomogeneity Index (GI). * Hemodynamic parameters (arterial blood pressure, heart rate, central venous pressure (CVP)). * P/F ratio (ratio of arterial oxygen tension to the fraction of inspired oxygen). * Transpulmonary pressures (end-expiratory transpulmonary pressure, end-inspiratory transpulmonary pressure, transpulmonary driving pressure). * Incidence of pneumonia, defined as received antibiotics with differential diagnosis of pneumonia, from day 2 till 5.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)